ENTA Enanta Pharmaceuticals Inc

USD 12.37 -0.11 -0.88141
Icon

Enanta Pharmaceuticals Inc (ENTA) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 12.37

-0.11 (-0.88)%

USD 0.31B

0.07M

USD 25.00(+102.10%)

USD 36.00 (+191.03%)

Icon

ENTA

Enanta Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 12.37
0.00 0
Take a Tour

Enanta Pharmaceuticals Inc (ENTA) Stock Forecast

Show ratings and price targets of :
USD 25.00
(+102.10%)

Based on the Enanta Pharmaceuticals Inc stock forecast from 3 analysts, the average analyst target price for Enanta Pharmaceuticals Inc is USD 25.00 over the next 12 months. Enanta Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Enanta Pharmaceuticals Inc is Bearish, which is based on 2 positive signals and 7 negative signals. At the last closing, Enanta Pharmaceuticals Inc’s stock price was USD 12.37. Enanta Pharmaceuticals Inc’s stock price has changed by -7.13% over the past week, -22.45% over the past month and -64.20% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...